These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7478273)

  • 1. Apoptosis and cell proliferation in human neuroepithelial tumors.
    Schiffer D; Cavalla P; Migheli A; Chiò A; Giordana MT; Marino S; Attanasio A
    Neurosci Lett; 1995 Aug; 195(2):81-4. PubMed ID: 7478273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
    Geiger KD; Stoldt P; Schlote W; Derouiche A
    Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material.
    Karamitopoulou E; Perentes E; Diamantis I; Maraziotis T
    Acta Neuropathol; 1994; 87(1):47-54. PubMed ID: 7511316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is polar spongioblastoma a tumor entity?
    Schiffer D; Cravioto H; Giordana MT; Migheli A; Pezzulo T; Vigliani MC
    J Neurosurg; 1993 Apr; 78(4):587-91. PubMed ID: 8450332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of apoptosis in the prognosis of oligodendrogliomas.
    Schiffer D; Dutto A; Cavalla P; Chiò A; Migheli A; Piva R
    Neurochem Int; 1997 Aug; 31(2):245-50. PubMed ID: 9220457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
    Deckert M; Reifenberger G; Wechsler W
    J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.
    Nakamizo A; Inamura T; Ikezaki K; Yoshimoto K; Inoha S; Mizoguchi M; Amano T; Fukui M
    J Neurooncol; 2002 Apr; 57(2):105-14. PubMed ID: 12125970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
    Zhang JM; Sun CY; Yu SZ; Wang Q; An TL; Li YY; Kong YL; Wen YJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):454-9. PubMed ID: 22088371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytologic diagnosis of glial tumors of the central nervous system].
    Shakunov AN; Triputin ES
    Arkh Patol; 1987; 49(1):41-6. PubMed ID: 3827633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of apoptotic pathways and c.Jun/JNK expression in malignant gliomas.
    Schiffer D; Ferracini R; Cavalla P
    Anticancer Res; 2001; 21(4A):2531-5. PubMed ID: 11724318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.
    Sarkar C; Pramanik P; Karak AK; Mukhopadhyay P; Sharma MC; Singh VP; Mehta VS
    J Neurooncol; 2002 Aug; 59(1):49-61. PubMed ID: 12222838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumours of the nervous system.
    Cardesa A; Rustia M; Mohr U
    IARC Sci Publ; 1982; (34):413-23. PubMed ID: 6301983
    [No Abstract]   [Full Text] [Related]  

  • 15. p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.
    Karamitopoulou E; Perentes E; Diamantis I
    Acta Neuropathol; 1993; 85(6):611-6. PubMed ID: 8337939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow-through fluorocytophotometry of different brain tumours.
    Lehmann J; Krug H
    Acta Neuropathol; 1980; 49(2):123-32. PubMed ID: 7355677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proliferation rate of intracranial tumors as defined by the monoclonal antibody KI 67. Application of the method to paraffin embedded specimens.
    Böker DK; Stark HJ
    Neurosurg Rev; 1988; 11(3-4):267-72. PubMed ID: 2855108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and survival in high-grade astrocytomas as related to tumor Fas (APO-1/CD95) expression.
    Frankel B; Longo SL; Leach C; Canute GW; Ryken TC
    J Neurooncol; 2002 Aug; 59(1):27-34. PubMed ID: 12222835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological grading of gliomas.
    Daumas-Duport C
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):924-31. PubMed ID: 1334739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correlation of neoplastic vulnerability with central neuroepithelial cytogeny and glioma differentiation.
    Rubinstein LJ
    J Neurooncol; 1987; 5(1):11-27. PubMed ID: 3037035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.